NorthRock Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,389
Closed -$229K 914
2025
Q2
$229K Sell
5,389
-13
-0.2% -$541 0.01% 606
2025
Q1
$241K Hold
5,402
0.01% 514
2024
Q4
$297K Buy
5,402
+7
+0.1% +$354 0.01% 476
2024
Q3
$228K Hold
5,395
0.01% 578
2024
Q2
$248K Buy
5,395
+6
+0.1% +$283 0.01% 522
2024
Q1
$280K Buy
+5,389
New +$236K 0.01% 495
2022
Q2
Sell
-5,498
Closed -$210K 349
2022
Q1
$210K Buy
5,498
+3
+0.1% +$108 0.02% 315
2021
Q4
$216K Buy
5,495
+21
+0.4% +$920 0.02% 308
2021
Q3
$267K Buy
5,474
+6
+0.1% +$311 0.02% 233
2021
Q2
$287K Buy
5,468
+41
+0.8% +$2.34K 0.02% 196
2021
Q1
$301K Buy
+5,427
New +$246K 0.03% 174
2019
Q1
Sell
-27,874
Closed -$485K 108
2018
Q4
$485K Buy
+27,874
New +$417K 0.14% 45

Other funds holding VCEL

NorthRock Partners's VCEL Position: Q3 2025 in Review

NorthRock Partners sold out of Vericel Corp (VCEL) in Q3 2025, closing a stake of 5,389 shares — an estimated $229K sold.

NorthRock Partners first reported a position in VCEL in Q4 2018 and held it in 12 quarters. The position peaked at $485K in Q4 2018. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

  • NorthRock Partners reported no remaining Vericel Corp position as of Q3 2025 after selling out during the quarter.
  • NorthRock Partners sold 5,389 Vericel Corp shares in Q3 2025, an estimated $229K.
  • NorthRock Partners first reported a position in Vericel Corp in Q4 2018 and held it in 12 quarters.
  • NorthRock Partners's Vericel Corp position peaked at $485K in Q4 2018.
  • 249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on NorthRock Partners's 13F filing for Q3 2025, filed 14 Nov 2025.